The Festival of Genomics & Biodata London 2027
27 January 2027 – 28 January 2027
ExCeL London, London, United Kingdom
The Festival of Genomics & Biodata is a two-day life sciences event organised by Front Line Genomics at ExCeL London. It brings together researchers, clinicians, industry and patient organisations across genomics, biodata, AI, multi-omics, diagnostics and precision medicine. The 2027 programme runs across 16 theatres with presentations, panels, workshops and roundtables, alongside an exhibition floor, poster zone and networking sessions. Invitation-only pre-day events take place on 26 January 2027.
238 sessions · 281 speakers
Sponsors (7)
Illumina · Roche · SOPHiA GENETICS · Congenica · Amazon Web Services · NHS England · Qiagen
Exhibitors (18)
Illumina · Hamilton · Roche · SOPHiA GENETICS · Beckman Coulter · Altheome · City St George's · Agilent Technologies · Congenica · Twist Bioscience · Nightingale Health · Cytiva · Unique · Amazon Web Services · Octapharma · Qiagen · Wellcome Genome Campus · Promega
Speakers (281)
- Sir Rory Collins Chief Executive & Principal Investigator, UK Biobank
- Giles Yeo Professor of Molecular Neuroendocrinology, University of Cambridge
- Elif Ozkirimli Head of Computational Science Products, Roche
- Alessandra Vigilante Reader in Bioinformatics, King's College London
- Inga Prokopenko Professor e-One Health and Head of Statistical Multi-Omics, University of Surrey
- Jan-Philipp Mallm Group Leader, Single Cell Open Lab, DKFZ German Cancer Research Center
- Melanie Ivarsson Chief Executive Officer, Health Data Research Service
- Nathalie Kingston Director, NIHR BioResource
- Pontus Skoglund Senior Group Leader, Francis Crick Institute
- Sam Jackson Programme Manager for Human Genomics & Translational Data, Elixir Europe
- Videha Sharma Clinical Innovation Lead, The University of Manchester
- Alireza Moayyeri Digital Transformation Lead RWE and Market Access, UCB
- Victor Hernandez CSO, Axovia Therapeutics
- Killian Hanlon CEO, Lir Therapeutics
- Trevor Graham ICR - Institute of Cancer Research
- Jacqueline Barry Chief Clinical Officer, Cell and Gene Therapy Catapult
- Lara Campana SVP, Head of Research and Translational Science, Resolution Therapeutics
- Aldo Faisal Professor and Director, UKRI Centres in AI for Health at Imperial College London
- Florent Mouliere Cancer Research UK Manchester Institute - The University of Manchester
- John Spoors Deputy Director of Medicines Evaluation, NICE
- Lennard Lee Oxford University, Jenner Institute, NDM, University of Oxford
- Lyn Chitty Genetics and Fetal Medicine at University College London
- Raghib Ali CEO, Our Future Health
- Adrian Freeman Executive Director, Head of Bioanalytical BioPharma Development, AstraZeneca
- James Staley Director of Computational Genetics, UCB
- Karen Sayal Translational AI Innovation Lead, University College London Hospitals NHS Foundation Trust
- Marisa Cunha Product Owner, Enterprise AI, AstraZeneca
- Nevena Cvetesic Associate Director, AstraZeneca
- Paidi Creed Vice President of Engineering, Relation Therapeutics
- Sam Cooper Director, Data/ML, Engitix Therapeutics
- Aarno Palotie Director of FinnGen and Professor, University of Helsinki
- Abigail Fraser Professor of Epidemiology, Bristol Medical School
- Adam Cribbs Co-Founder & CTO, Entelo Bio
- Adam Rosenthal Professor of Gynaecological Cancer Prevention, University College London
- Adam Rutherford Scientist, Author, and Broadcaster
- Adam Steventon Chief Data Officer, Our Future Health
- Aditi Vedi Consultant Paediatric Oncologist, Cambridge University Hospital NHS Foundation Trust
- Adrian Thrasher Professor in Paediatric Immunology and Wellcome Trust SRF, University College London
- Agne Antanaviciute Group Leader in Computational Biology, University of Oxford
- Aida Andres Professor of Population and Evolutionary Genomics, University College London
- Alan Hodgkinson Senior Lecturer, King's College London
- Aleix Lafita Associate Director, Translational Sciences, GSK
- Alessandra Devoto Professor of Molecular Plant Biology, Royal Holloway, University of London
- Alex Clipson Deputy Team Lead, Cancer Research UK Manchester
- Alex Frankell Group Leader, University of Cambridge
- Alex Koers Associate Director, Bioscience, AstraZeneca
- Alex Mentzer NIHR Academic Clinical Lecturer, University of Oxford
- Alison Fildes Associate Professor, University of Leeds
- Altuna Akalin Head of Bioinformatic and Omics Data Science Platform, Max Delbrück Center for Molecular Medicine
- Amaia Vilas Zorno Senior Director, Molecular Profiling & Sequencing, Relation Therapeutics
- Amaka Offiah Professor of Paediatric Musculoskeletal Imaging, University of Sheffield
- Amanda Pichini Clinical Director, Genomics England
- Amonida Zadissa Associate Director of Informatics, UK Dementia Research Institute
- Amy Jayne McKnight Professor of Molecular Epidemiology & Public Health, Queen's University Belfast
- Andrew Beggs Professor of Cancer Genetics & Surgery, University of Birmingham
- Andrew Champion Programme Director, AWTTC
- Andrew Pestaille Principal Genetic Counsellor, St George's University Hospitals NHS Foundation Trust
- Angela Brueggemann Professor of Infectious Disease Epidemiology, Deputy Head of Department, Nuffield Department of Population Health
- Angelica Ronald Professor of Psychology and Genetics, University of Surrey
- Anke-Hilse Maitland-van der Zee Head of Department of Genetics and Professor of Personalised Medicine, University Medical Centre Groningen
- Ann Brine Head of Marketing Services, Promega
- Anna David Professor of Obstetrics and Maternal Fetal Medicine, University College London
- Anna Schuh Director of Molecular Diagnostics, University of Oxford
- Annelise Vuidepot SVP, Chief Science & Technology Officer and UK Site Head, Immunocore
- Anthony Pereira Consultant & Hon. Reader in Neurology, St George's Hospital
- Anthony Sullivan Chief Operating Officer, North Thames Genomic Medicine Service
- Arianna Tucci Clinical Reader in Genomic Medicine, Queen Mary University of London
- Aroon Hingorani Professor of Genetic Epidemiology, University College London
- Augusto Rendon Chief Bioinformatician, Genomics England
- Aybuke Kupcu Yoldas BioImage Archive Data Project Leader, EBI
- Aylwyn Scally Associate Professor, University of Cambridge
- Barbara Franke Professor of Molecular Psychiatry, Radboud University Medical Center
- Ben O'Leary Group Leader: Evolution and Translational Genomics, The Institute of Cancer Research
- Beverley O'Hara Public Health Nutritionist, Leeds Beckett University
- Bill Newman Clinical Director and Consultant in Genomic Medicine, The NHS North West Genomic Medicine Service Alliance and Manchester University Foundation Trust
- Bodhayan Prasad Bioinformatician, University of Glasgow
- Bridget Penman Associate Professor of Zoonoses and One Health, University of Oxford
- Caroline Weis Director, AI for Science, GSK
- Chantal Ebel Associate Professor, University of Sfax
- Charlie Gourley Professor and Honorary Consultant in Medical Oncology, University of Edinburgh
- Charlie Rowlands Bioinformatician, Institute of Cancer Research
- Christoph Ogris Head of Computational Biology, DISCO Pharmaceuticals
- Cindy Pamela Ulloa Guerrero Bioinformatician (Spatial Image Analysis), DKFZ
- Claire Booth Consultant Paediatric Immunologist, UCL Great Ormond Street Institute of Child Health
- Clara Albiñana Lundbeck Postdoctoral Fellow, University of Oxford
- Clara Cieza-Borrella Senior Lecturer in Molecular Biology, City St George's, University of London
- Clare Llewellyn Professor of Psychology and Epidemiology, University College London
- Clare Turnbull Professor of Cancer Genetics, The Institute of Cancer Research
- Claudia Langenberg Director, PHURI, Queen Mary University of London
- Claudia Lindner Senior Research Fellow in Translational Medical Imaging, University of Manchester
- Cosima Gretton Chief Product Officer, Our Future Health
- Daljeet Bansal NPIC Director of Operations, Leeds Teaching Hospitals NHS
- Damian Smedley Professor of Computational Genomics, Queen Mary University of London
- Dan Marks Bioimaging Bioinformatician, EBI
- Daniel Seaton Scientific Director, Computational Biology, GSK
- Daniele Filiault Senior Data Scientist, Bayer Crop Science
- Dario Bressan Head of Spatial Profiling and Annotation Centre of Excellence (SPACE), University of Cambridge
- Dave Bohanna Business Development Manager, HCPC Registered Clinical Scientist, Oxford Gene Technology
- David Gems Professor of Biogerontology, University College London
- Debbie Clapham Research Ethics Manager, NIHR BioResource
- Deborah Porter Deputy Director Genomics Service Transformation, NHS England
- Deborah Richards VP & General Manager, UK & Ireland, Alexion, AstraZeneca Rare Disease
- Deborah Williamson Co-Director, The Scottish Pandemic Sciences Partnership
- Deena Gendoo Associate Professor in Computational Biology, University of Birmingham
- Derk-Jan Dijk Director, Surrey Sleep Research Centre
- Dr Maria C Suciu Head of Discovery, Genomics Ltd
- Edith Heard Director and Chief Executive, The Francis Crick Institute
- Eilis Hannon Associate Professor in Bioinformatics, Complex Disease Epigenetics Group, University of Exeter
- Elina Nagaeva Postdoctoral Researcher, UK DRI
- Elisabetta Leo Senior Director, Early Development Asset Lead, Ipsen
- Elvira Bramon Hon. Consultant Psychiatrist, North London NHS Foundation Trust
- Emanuele Di Angelantonio Deputy-Director of the Cardiovascular Epidemiology Unit, University of Cambridge
- Emily Jefferson Director of DARE/Strategic Advisor (Technology), UKRI/HDR UK
- Emily Merrell Director of Advanced Therapy Treatment Centre Network, Cell and Gene Therapy Catapult
- Emma Baple Professor of Genomic Medicine, University of Exeter
- Emma Davenport Group Leader, Wellcome Sanger Institute
- Emma-Jane Cassidy Principal Clinical Scientist in Rare Disease Genomics, NHS
- Eva Winnebeck Assistant Professor in Chronobiology, University of Surrey
- Evie Stergiakouli Professor of Genetic Epidemiology and Public Mental Health, University of Bristol
- Fazeleh Hoseini AI Privacy Researcher & Project Lead, AI Sweden
- Federica Eduati Associate Professor, Technische Universiteit Eindhoven
- Fiona Maleady-Crowe Chief Compliance and Integrity Officer, Our Future Health
- Gaia Cantelli Director of NURTuRE, Kidney Research UK
- Gareth Masson Data and Informatics Lead, Central and South Genomic Medicine Service
- Gemma Walton Associate Professor in Metagenomics, University of Reading
- Georg Zeller Professor, Leiden University Medical Center
- Georgios Baskozos Associate Professor, University of Oxford
- Gerard Evan Principal Group Leader, Francis Crick Institute
- Gillian Reeves Professor of Epidemiology and Director of the Cancer Epidemiology Unit, University of Oxford
- Gillian Reynolds Senior Bioinformatician, Earlham Institute
- Gosia Trynka Science Director, OpenTargets
- Graham Belfield Director NGS & Transcriptomics, AstraZeneca
- Guy Maissis Clinical Psychologist, Royal Free London NHS Foundation Trust
- Harpreet Saini Senior Director, Bioinformatics, Astex Pharmaceuticals
- Helen Winter Honorary Professor / Clinical Director, University of Bristol / SWAG Cancer Alliance
- Helena Andres Terre Associate Director, AI & Advanced Analytics, UCB
- Hemanth Tummala Senior Lecturer of Genetics and Molecular Biology, Queen Mary University of London
- Holger Klein Senior Principal Scientist Computational Innovation, Boehringer Ingelheim
- Ian Simpson Professor of Biomedical Informatics & Director UKRI Artificial Intelligence CDT in Biomedical Innovation, University of Edinburgh
- Ilaria Bellantuono Professor of Musculoskeletal Ageing, University of Sheffield
- Jake Taylor-King Chief Innovation Officer, Relation Therapeutics
- James Brenton Professor of Ovarian Cancer Medicine, Cancer Research UK - Cambridge Institute
- James Doroghazi Head of Traits Digitalisation and Genomics, Syngenta Seeds
- James Opzoomer Senior Scientist, Innovation Lab, Relation Therapeutics
- James Pound Interim Executive Director of Innovation and Compliance, MHRA
- Jann Gardner Chief Executive, NHS Greater Glasgow and Clyde
- Jason Hodgson Senior Lecturer in Bioinformatics and Big Data, Anglia Ruskin University
- Jay Moore PhD Student, UK DRI
- Jemma Hopewell Professor of Precision Medicine & Epidemiology, University of Oxford
- Jemma Longley Consultant in Medical Oncology, University Hospital Southampton
- Joachim De Jonghe Senior Scientist, Relation Therapeutics
- Joe Marsh Professor and Personal Chair of Computational Protein Biology, University of Edinburgh
- John Fraser Head of Data and Informatics Genomics Unit, NHS England
- John Tadross Consultant in Histopathology and Solid Tumour Molecular Pathology, Cambridge University Hospitals NHS Foundation Trust
- Jonathan Mill Professor of Epigenomics, University of Exeter Medical School
- Jordana Bell Professor of Epigenomics, King's College London
- Joris Deelen Associate Professor, Leiden University Medical Center
- Joseph Halstead Lead Bioinformatician, Cardiff and Vale University Health Board
- Joshua Bull Group Leader, Francis Crick Institute
- Joyce Harper Professor of Reproductive Medicine, University College London
- Jude Hayward Principal Clinician – Primary Care, Genomics England
- Julia Carrasco-Zanini Sanchez Lecturer in Multiomic Science, Queen Mary University of London
- Julian Parkhill Professor, University of Cambridge
- Julianne Brown Principal Clinical Scientist, Great Ormond Street Hospital
- Julio Saez-Rodriguez Head of Research, EMBL-EBI
- Kate Everett Reader in Human Genetics, City St George's, University of London
- Kate Tatton Brown Consultant in Clinical Genetics, St George's University Hospital
- Kathy Stirrups Head of Samples, NIHR BioResource
- Katie Wilde HDRUK Scotland Co-Director, University of Aberdeen
- Kerstin Haase Senior Research Fellow, University College London
- Kevin Foster Professor of Microbiology, University of Oxford
- Kingyin Lee Head of Clinical Trials, MHRA
- Laura Jardine Senior Clinical Lecturer and Honorary Consultant, Newcastle University
- Layla Afkhami Scientific Training Officer (Practice Educator), Synnovis, Guy's Hospital
- Lesley Hoyles Professor of Microbiome and Systems Biology, Nottingham Trent University
- Linda Partridge Professorial Research Fellow, University College London
- Liz Merrifield Informaiton Governance Lead, Wales Gene Park
- Loukas Theodosiou Senior Bioinformatics Scientist, Max Planck Institute for Evolutionary Biology
- Luca Magnani Honorary Principal Research Fellow, Imperial College London
- Majd Saleh Senior Data Scientist, Servier Institute of Therapeutic Innovation
- Marc Boubnovski Martell Machine Learning Researcher, Novo Nordisk
- Marco Maccaferri Associate Professor of Agricultural Genetics, University of Bologna
- Marion Hitchcock Managing Director, CGT Incubator, Bayer
- Mark Coles Professor of Immunology, University of Oxford
- Mark Hartmann Team Leader, German Cancer Research Center (DKFZ)
- Marlen Lauffer DRM Transition Research Fellow, University of Oxford
- Martin Maiden Professor of Molecular Epidemiology, University of Oxford
- Martin Miller Executive Director, Data Science, GSK
- Martin Rutter Deputy Chief Scientist, UK Biobank
- Marton Olbei Teaching Fellow, Imperial College London
- Matt Silver Associate Professor of Epigenetic Epidemiology, London School of Hygiene and Tropical Medicine & MRC Unit The Gambia
- Matthew Hurles Director, Wellcome Sanger Institute
- Matthew Krebs Cancer Medical Lead, North West Genomic Laboratory Hub
- Matthew Loose Professor of Developmental and Computational Biology, University of Nottingham
- Mayuri Basnet Consultant Histopathologist, Northern Care Alliance NHS Foundation Trust
- Melanie Bailey Professor, King's College London
- Melina Velasquez Bioimaging Data Steward, EBI
- Meng Khaw National Director, Health Protection and Screening Services, Public Health Wales
- Michael Hubank Scientific Director of Clinical Genomics, The Royal Marsden NHS Foundation Trust
- Michael Inouye Professor of Systems Genomics & Population Health, University of Cambridge
- Michael Quail Principal Scientific Manager Sequencing R&D, Wellcome Sanger Institute
- Michele Bortolomeazzi Bioinformatician, DKFZ
- Mina Ryten Honorary Professor and Professor and Director of the Dementia Research Institute, UCL and University of Cambridge
- Miranda Durkie Consultant Clinical Scientist, Rare Disease Lead, North East Yorkshire Genomic Laboratory Hub
- Miten Jain Assistant Professor, Bioengineering, Northeastern University
- Moez Hanin Professor and Head of the Functional Genomics and Plant Physiology Laboratory, University of Sfax
- Molly Stevens John Black Professor of Bionanoscience, University of Oxford
- Mrinal Joshi Research Assistant, UK DRI
- Muzlifah Haniffa Head of Cellular Genomics Programme and Deputy Director, Wellcome Sanger Institute
- Natalie Cook Honorary Consultant in Medical Oncology and Clinical Senior Lecturer (ECMT), The Christie NHS Foundation Trust
- Nathan Skene Associate Professor Brain Sciences, Imperial College London
- Nicholas Hickson Scientific Education and Training Lead, South East Genomic Laboratory Hub / Synnovis
- Nicola Segata Principal Investigator, University of Trento
- Nicola Taverner Clinical Lead, Health Education and Improvement Wales (HEIW)
- Nicola Wilson Professor, University of Cambridge
- Nikolai Hecker Senior Bioinformatician, UK Dementia Research Institute
- Nilufer Rahmioglu Senior Research Scientist, University of Oxford
- Nirupa Murugaesu Consultant in Molecular Oncology, Guy's and St Thomas' NHS Foundation Trust
- Oisin Brady PhD Student, Cardiff University
- Oliver Stegle Division Head and Group Leader, EMBL
- Petra Korlevic Staff Scientist, Wellcome Sanger Institute
- Rachel Hart Deputy Clinical Director (Genomics), North West Genomic Service Alliance
- Rachel Palmer Consultant Pharmacist Genomic Medicine, NHS South West Genomic Medicine Service
- Rebecca Rohrer Clinical Innovation and Genomics Director, Bupa
- Remy Adriaensen Lead OSR Discovery Breeder Europe, BASF
- Riccardo Marioni Professor of Molecular Epidemiology of Ageing, University of Edinburgh
- Roberta Rizzo Consultant Genetic Counsellor, Oxford University Hospitals NHS Foundation Trust
- Robin Flaig Co-Director, UK Longitudinal Linkage Collaboration & COO, Generation Scotland, The University of Edinburgh
- Rodrigo Toledo Group Leader, Biomarkers and Clonal Dynamics Group, VHIO
- Rosalind Eeles Professor of Oncogenetics, The Institute of Cancer Research
- Roser Vento-Tormo Group Leader, Wellcome Sanger Institute
- Russell Foster Director, Sir Jules Thorn Sleep and Circadian Neuroscience Institute
- Ruth Loos Professor, University of Copenhagen
- Sam Behjati Group Leader, Wellcome Sanger Institute
- Sam Speak Postdoctoral Research Scientist, Earlham Institute
- Sandosh Padmanabhan Chair of Pharmacogenomics, University of Glasgow
- Sankari Nagarajan Lecturer in Chromatin Biology, University of Manchester
- Sarah Coupland Professor and Honorary Consultant in Pathology, University of Liverpool
- Serena Scollen Head of Human Genomics and Translational Data, ELIXIR
- Sergii Strelchuk Associate Professor of Computer Science, University of Oxford
- Shaheer Saeed Lecturer in Computational Biomedical Engineering, Queen Mary University of London
- Shankar Srinivas Professor of Developmental Biology, University of Oxford
- Sikha De Souza Consultant in Public Health with Screening Division, Deputy Medical Director, Public Health Wales
- Silvia Surinova Team Lead in Proteomics, University College London
- Sir Mark Caulfield Professor of Clinical Pharmacology, Queen Mary University of London
- Slavica Dimitrieva Associate Director, Oncology Data Science, Novartis
- Sneha Jha R&D Lead, The Queen's University Belfast
- Sofia Kudasheva Postdoctoral Researcher, Wellcome Sanger Institute
- Sonam Vadera RCR AI Course Lead, The Royal College of Radiologists
- Sophia Varadkar Chief Medical Officer, Great Ormond Street Hospital
- Sophie Harding Pharmacogenomics Lead, All Wales Medical Genomics Service
- Sophie Kellaway Assistant Professor, Faculty of Medicine & Health Sciences, University of Nottingham
- Sophien Kamoun Group Leader, The Sainsbury Laboratory
- Stefan Harrer VP, Global Head R&D, AI and Computational Sciences, Sanofi
- Stephan Sanders Professor of Paediatric Neurogenetics / Director, University of Oxford / MRC CoRE - Therapeutic Genomics
- Stephanie Francis Programme Manager, AWTTC
- Stephen Franks Emeritus Professor of Reproductive Endocrinology, Imperial College London
- Steven Penfield Professor and Group Leader, John Innes Centre
- Stuart Lowe Head of Advanced Therapies, TTP
- Sumeet Pandey Associate Director, Translational Unit (Multi-Omics), GSK
- Susan Jebb Professor of Diet and Population Health, University of Oxford
- Susanna Slater Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust
- Tamas Korcsmaros Associate Professor in Intestinal Epithelial Systems, Imperial College London
- Tanya Monaghan Clinical Associate Professor and Honorary Consultant Gastroenterologist, University of Nottingham
- Tassos Georgiadis SVP Discovery & Preclinical Development, MeiraGTx
- Teresa Zulueta-Coarasa Technical Coordination Project Leader, EBI
- Tim Mauchline Plant and Soil Microbiologist, Rothamsted Research
- Timothy Walsh Professor of Medical Microbiology / Director of Biology, University of Oxford / Ineos Oxford Institute
- Tommy Kaplan Professor of Computational Biology, Queen Mary University of London and The Hebrew University of Jerusalem
- Torsten Haferlach Co-Founder and CEO, Munich Leukemia Laboratory (MLL)
- Trevor Lawley Senior Group Leader, Wellcome Sanger Institute
- Turi King Geneticist, Presenter, Author and Director of the Milner Centre for Evolution, The University of Bath
- Vanessa Sancho-Shimizu Professor of Human Genetics in Infectious Disease, Imperial College London
- Vera Bonardi Microbial Discovery Portfolio Leader, Corteva Agriscience
- Vicki Heath Chief Healthcare Science Officer, Welsh Government
- Victoria Sanz-Moreno Professor and Group Leader, The Institute of Cancer Research
- Wendy Bickmore Director of the MRC Human Genetics Unit, University of Edinburgh
- William Bradlow Consultant Cardiologist, University Hospitals Birmingham
- Dame Anna Dominiczak Chief Scientific Adviser (Health), Scottish Government
- Naomi Allen Chief Scientist, UK Biobank
- Richard Rosenquist Brandell Director, Genomic Medicine Sweden
Agenda
Showing 80 of 238 sessions.
- Spatial Omics Data Workshop: A Practical Introduction to Working with Spatial Omics Data 26 January 2027
- PharmAI Leaders’ Exchange: Turning AI Potential into Measurable Impact Across Drug Discovery 26 January 2027
- AI-Ready Biopharma Data Leaders’ Exchange: Create an Environment in Which Scientific Data Can Remain Interpretable, Accessible and Valuable Over Time 26 January 2027
- The Next Chapter of Genomic Medicine 27 January 2027 · Main Stage
- Unlocking the UK's Health Data Potential: The Vision and Future of HDRS 27 January 2027 · Main Stage
- PANEL DISCUSSION: The UK's Health Data Advantage: Powering the Future of Life Sciences 27 January 2027 · Main Stage
- UK Biobank: Unlocking the Power of Population-Scale Data for Science and Health 27 January 2027 · Biodata Stage
- How Can Cancer Genomics Be Optimised To Maximise Patient Benefit Without Bankrupting The NHS? 27 January 2027 · Cancer Diagnostics Stage
- Why Do We Sleep? 27 January 2027 · The Live Lounge
- Cell Identity, Plasticity and Therapeutic Vulnerabilities in Cancer 27 January 2027 · Epigenetics & Translational Omics Stage
- Relation's AI & Deep Learning Platform: What datasets the ML models are trained on 27 January 2027 · AI In Drug Discovery Stage
- AI Agents for Rare Disease Diagnosis: Accelerating Variant Interpretation in Clinical Genomics 27 January 2027 · AI-Enabled Diagnostics Stage
- Pharmacogenomics in Healthcare 27 January 2027 · Pharmacogenomics & Patient Stratification Stage
- Preeclampsia and Fetal Growth Restriction: From Prediction to Prevention 27 January 2027 · Women & Children's Health Stage
- Direct RNA Sequencing: Unlocking the Native RNA Landscape 27 January 2027 · Main Stage
- Pangenome Graphs as a Multi-Omics Operating System for AI Agents and Foundation Models 27 January 2027 · Plant Genomics Stage
- Integrating Spatial Multi-Omics: From Technology Development to Biological Discovery 27 January 2027 · Spatial Stage
- Proteomics to Identify Disease-Associated Variants in Patients with Rare Disease Undiagnosed After Genome Sequencing 27 January 2027 · Multi-Omics Stage
- Data Viz at the Speed of AI: Solid Foundations, Faster Execution 27 January 2027 · Workshop Room
- Single-Cell DNA Sequencing: Balancing Sensitivity, Throughput and Biological Insight 27 January 2027 · Single-Cell Stage
- What Do We Need to Get More Advanced Therapies to Patients? 27 January 2027 · Advanced Therapies Stage
- Interactive Session: Building Trust in AI – Identifying Bias, Data Leakage and Hidden Failure Modes 27 January 2027 · Genome Dome
- Rethinking Cholera - How Genomics Transformed Our Understanding of a Global Pandemic 27 January 2027 · Bacteria, Bugs & Big Data Stage
- Orchestrating Mainstream Genomics: A Blueprint for Clinical Integration 27 January 2027 · Genomic Medicine Stage
- A National Approach to Pharmacogenomics: Developments in Wales 27 January 2027 · Pharmacogenomics & Patient Stratification Stage
- Is It Really Modern Life That Is Breaking Our Sleep? 27 January 2027 · The Live Lounge
- Causal by Design: Genetics-First Discovery Combined with Agentic AI as the Engine of Next-Generation Therapeutics 27 January 2027 · Multi-Omics Stage
- Mainstreaming: Lessons Learned 27 January 2027 · Genomic Medicine Stage
- Leveraging Genomic Sequence-to-Function Language Models for the Design of Antisense Oligonucleotides 27 January 2027 · AI In Drug Discovery Stage
- Sequence Data for Outbreak Intelligence: Gene-by-Gene Genomics and Population Annotation in Pathogen Surveillance 27 January 2027 · Bacteria, Bugs & Big Data Stage
- Polygenic Risk Scores for Prostate Cancer Risk Stratification - Lessons From the BARCODE1 Study 27 January 2027 · Cancer Diagnostics Stage
- How The Wheat Pangenome is Transforming Research and Breeding 27 January 2027 · Plant Genomics Stage
- Spatial Total RNA Profiling via in situ Polyadenylation 27 January 2027 · Spatial Stage
- What Does Your Sleep Pattern Say About You and Our Society? 27 January 2027 · The Live Lounge
- Quantitative Proteomics to Unravel Signaling in Rare Cells 27 January 2027 · Multi-Omics Stage
- Taking Single Cell mRNA Sequencing to the Bedside 27 January 2027 · Single-Cell Stage
- From Evidence to Infrastructure: Building Pharmacogenomics at National Scale — The Scottish Perspective 27 January 2027 · Pharmacogenomics & Patient Stratification Stage
- Challenges and Opportunities in Translating Cancer Epigenetics into Clinical Practice 27 January 2027 · Epigenetics & Translational Omics Stage
- Direct-to-Patient (DTP) Genetic Testing Pathways: Unlocking Capacity For The NHS Genomic Medicine Service and Genomic Population Health Service 27 January 2027 · Genomic Medicine Stage
- Panel Discussion: Designing the Next Generation of Rare Disease Therapies: From Advanced Genomics to AI-Enabled Therapeutic Innovation 27 January 2027 · Advanced Therapies Stage
- What We've Been Missing: Unlocking New Discoveries Through Large-Scale Long-Read Sequencing 27 January 2027 · Main Stage
- Building Europe’s Federated Genomics Infrastructure: From Technical Foundations to Data at Scale 27 January 2027 · Biodata Stage
- Towards Nucleotide Resolution Genomic Medicine: Scaling MAVEs 27 January 2027 · AI-Enabled Diagnostics Stage
- Pregnancy as a Window into Immune and Disease Biology 27 January 2027 · Women & Children's Health Stage
- Career Taster - Clinical Scientist In Genomics 27 January 2027 · Workshop Room
- Linking Epigenetic Silencing in the Early Embryo to the Developmental Origins of Disease 27 January 2027 · Epigenetics & Translational Omics Stage
- Making AMR Diagnostics Work Where They Matter Most: Genomics, Sepsis and Sustainable Implementation 27 January 2027 · Bacteria, Bugs & Big Data Stage
- Unlocking Hidden Maize Diversity: Using Pangenomics to Bring Historical Germplasm into Modern Breeding 27 January 2027 · Plant Genomics Stage
- Is Precision Medicine the Future of Obesity Care? 27 January 2027 · The Live Lounge
- Design and Translation of Next Generation Delivery Vehicles for Advanced Therapeutics 27 January 2027 · Advanced Therapies Stage
- Trust in the Data Age: Who Should Access Our Genomic Data and Why? 27 January 2027 · Genome Dome
- MAVEs: Multiplex Assays of Functional Effect: Saying Goodbye To VUSs? 27 January 2027 · Cancer Diagnostics Stage
- Making Biobank Data Useful for Drug Discovery 27 January 2027 · Multi-Omics Stage
- Resolving RNA Diversity in Neurodegenerative Disease: From Mechanism to Therapeutic Targeting 27 January 2027 · Main Stage
- The Generation Study: Insights From a National Study of Newborn Genome Sequencing 27 January 2027 · Women & Children's Health Stage
- Protein AI Models for Drug Discovery 27 January 2027 · AI In Drug Discovery Stage
- Progress in Spatially Resolved, Single and Sub-Cellular Omics at the SEISMIC Facility 27 January 2027 · Single-Cell Stage
- Agentic AI for Life Sciences: Build Your Own AI Research Assistant 27 January 2027 · Workshop Room
- From Cells to Code: Building AI-Enabled Multimodal Diagnostics for Precision Haematology 27 January 2027 · AI-Enabled Diagnostics Stage
- Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources? 27 January 2027 · Biodata Stage
- Mapping the Invasive Tumour: How Spatial Biology is Revealing Cancer's Next Move 27 January 2027 · Spatial Stage
- Taking the 'U' out of CUP: Implementing Genomic Diagnostics as Standard of Care 27 January 2027 · Genomic Medicine Stage
- From Risk Prediction to Precision Prevention 27 January 2027 · Pharmacogenomics & Patient Stratification Stage
- Is Shift Work Rewiring Our Metabolism? 27 January 2027 · The Live Lounge
- A Multi-Omic and Ethical Framework for Newborn Screening in Wales 27 January 2027 · Women & Children's Health Stage
- From Diagnosis to Delivery: Making Rare Disease Genomics Work in Routine Care 27 January 2027 · Genomic Medicine Stage
- Streamlining and Accelerating Health Data Discovery and Access 27 January 2027 · Biodata Stage
- Unlocking Legacy Data for AI: Building Multimodal Datasets Across Genomics, Pathology and Imaging 27 January 2027 · AI-Enabled Diagnostics Stage
- Beyond the Diagnostic Odyssey: What Comes After Genomic Diagnosis? 27 January 2027 · Women & Children's Health Stage
- Tracking the Emergence and Spread of Antimicrobial Resistance Through Bacterial Genomics 27 January 2027 · Bacteria, Bugs & Big Data Stage
- Population Proteomics at Scale: How UK Biobank Is Transforming Drug Discovery and Precision Medicine 27 January 2027 · Multi-Omics Stage
- Single-Cell for Studying Rare Leukaemia Stem Cells 27 January 2027 · Single-Cell Stage
- Tracing Metastatic Evolution with Spatial Biology: Insights for Immunity and Immune Evasion 27 January 2027 · Spatial Stage
- From Tetraploid Wheat Diversity to Deployable Alleles for Crop Improvement 27 January 2027 · Plant Genomics Stage
- From Pilot to Implementation: Bupa’s Use of Genomics for Personalised, Preventive Care 27 January 2027 · Pharmacogenomics & Patient Stratification Stage
- Cell-Type-Specific Isoform Dysregulation in Crohn's Disease: Insights from Single-Cell Long-Read Sequencing 27 January 2027 · Main Stage
- Applying Genomics at Population Scale: From Inherited Disease to Common Conditions 27 January 2027 · Genomic Medicine Stage
- Applying AI for Oncology Drug Target Identification & Prioritisation 27 January 2027 · AI In Drug Discovery Stage
- Exploiting Genome Evolution in Inflammatory Bowel Disease to Prevent Colorectal Cancer 27 January 2027 · Cancer Diagnostics Stage
- Engineering the Next Generation of Immunotherapies: Lessons from the First Approved T Cell Receptor-Based Therapy 27 January 2027 · Advanced Therapies Stage